Journal article
The EHA Research Roadmap: normal hematopoiesis
- Abstract:
- In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1–2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 852.4KB, Terms of use)
-
- Publisher copy:
- 10.1097/hs9.0000000000000669
Authors
- Publisher:
- Lippincott, Williams & Wilkins
- Journal:
- HemaSphere More from this journal
- Volume:
- 5
- Issue:
- 12
- Article number:
- e669
- Place of publication:
- United States
- Publication date:
- 2021-12-01
- Acceptance date:
- 2021-11-02
- DOI:
- EISSN:
-
2572-9241
- Pmid:
-
34853826
- Language:
-
English
- Pubs id:
-
1231497
- Local pid:
-
pubs:1231497
- Deposit date:
-
2023-11-09
- ARK identifier:
Terms of use
- Copyright holder:
- Jaffredo et al.
- Copyright date:
- 2021
- Rights statement:
- © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
If you are the owner of this record, you can report an update to it here: Report update to this record